386 related articles for article (PubMed ID: 15076285)
41. Effect of healthcare provider characteristics on nodal yield at radical cystectomy.
Kulkarni GS; Finelli A; Lockwood G; Saravanan A; Evans A; Jewett MA; Trachtenberg J; Robinette M; Fleshner NE
Urology; 2008 Jul; 72(1):128-32. PubMed ID: 18455773
[TBL] [Abstract][Full Text] [Related]
42. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
Suzuki K; Morita T; Tokue A
Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
[TBL] [Abstract][Full Text] [Related]
43. Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004.
Hellenthal NJ; Ramírez ML; Evans CP; deVere White RW; Koppie TM
J Urol; 2009 Jun; 181(6):2490-5. PubMed ID: 19371902
[TBL] [Abstract][Full Text] [Related]
44. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
[TBL] [Abstract][Full Text] [Related]
45. Laparoscopic radical cystectomy and extracorporeal urinary diversion: a single center experience of 48 cases with three years of follow-up.
Hemal AK; Kolla SB; Wadhwa P; Dogra PN; Gupta NP
Urology; 2008 Jan; 71(1):41-6. PubMed ID: 18242362
[TBL] [Abstract][Full Text] [Related]
46. Pathologic evaluation of radical cystectomy specimens: a cooperative group report.
Herr HW; Faulkner JR; Grossman HB; Crawford ED
Cancer; 2004 Jun; 100(11):2470-5. PubMed ID: 15160354
[TBL] [Abstract][Full Text] [Related]
47. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?
Koppie TM; Vickers AJ; Vora K; Dalbagni G; Bochner BH
Cancer; 2006 Nov; 107(10):2368-74. PubMed ID: 17041887
[TBL] [Abstract][Full Text] [Related]
48. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy.
Wiesner C; Pfitzenmaier J; Faldum A; Gillitzer R; Melchior SW; Thüroff JW
BJU Int; 2005 Feb; 95(3):301-5. PubMed ID: 15679782
[TBL] [Abstract][Full Text] [Related]
49. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
50. Variation in use of lymph node dissection during radical cystectomy for bladder cancer.
Hedgepeth RC; Zhang Y; Skolarus TA; Hollenbeck BK
Urology; 2011 Feb; 77(2):385-90. PubMed ID: 21145577
[TBL] [Abstract][Full Text] [Related]
51. [Clinical significance of pelvic lymph-node dissection for the patients with locally invasive bladder cancer--correlation between the number of retrieved lymph nodes and prognosis].
Noguchi S; Takase K; Oogo Y; Muraoka K; Shioi K; Nakamura M; Onuki T; Kishi H; Satomi Y; Fukuda M
Hinyokika Kiyo; 2006 May; 52(5):327-30. PubMed ID: 16758719
[TBL] [Abstract][Full Text] [Related]
52. Lymph node dissection for bladder cancer: the issue of extent and feasibility in the minimally invasive era.
Ghavamian R; Hakimi AA
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1783-92. PubMed ID: 19954290
[TBL] [Abstract][Full Text] [Related]
53. Re: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.
Thompson IM
J Urol; 2001 Aug; 166(2):630. PubMed ID: 11458100
[No Abstract] [Full Text] [Related]
54. Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes.
Meijer RP; Nunnink CJ; Wassenaar AE; Bex A; van der Poel HG; van Rhijn BW; Meinhardt W; Horenblas S
J Urol; 2012 Feb; 187(2):446-50. PubMed ID: 22177147
[TBL] [Abstract][Full Text] [Related]
55. Is patient outcome compromised during the initial experience with robot-assisted radical cystectomy? Results of 164 consecutive cases.
Hayn MH; Hellenthal NJ; Seixas-Mikelus SA; Mansour AM; Stegemann A; Hussain A; Guru KA
BJU Int; 2011 Sep; 108(6):882-7. PubMed ID: 21166749
[TBL] [Abstract][Full Text] [Related]
56. Pelvic lymphadenectomy during radical cystectomy: a review of the literature.
Hurle R; Naspro R
Surg Oncol; 2010 Dec; 19(4):208-20. PubMed ID: 19500973
[TBL] [Abstract][Full Text] [Related]
57. Pathological evaluation and quality of surgery in radical cystectomy in New South Wales, Australia.
Ahmadi N; Delprado WJ; Brooks AJ; Brenner PC; Coombes GM; Grant A; Patel MI
ANZ J Surg; 2015 Mar; 85(3):145-9. PubMed ID: 25410154
[TBL] [Abstract][Full Text] [Related]
58. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall.
Poulsen AL; Horn T; Steven K
J Urol; 1998 Dec; 160(6 Pt 1):2015-9; discussion 2020. PubMed ID: 9817313
[TBL] [Abstract][Full Text] [Related]
59. The prognostic and staging value of lymph node dissection in the treatment of invasive bladder cancer.
Sanderson KM; Skinner D; Stein JP
Nat Clin Pract Urol; 2006 Sep; 3(9):485-94. PubMed ID: 16964190
[TBL] [Abstract][Full Text] [Related]
60. Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer.
Bruins HM; Stein JP
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1091-101. PubMed ID: 18588454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
